Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant

PLoS One. 2013 Nov 21;8(11):e81303. doi: 10.1371/journal.pone.0081303. eCollection 2013.

Abstract

Recent studies indicate that defective activity of complement factor H (FH) is associated with several human diseases, suggesting that pure FH may be used for therapy. Here, we describe a simple method to isolate human FH, based on the specific interaction between FH and the hypervariable region (HVR) of certain Streptococcus pyogenes M proteins. Special interest was focused on the FH polymorphism Y402H, which is associated with the common eye disease age-related macular degeneration (AMD) and has also been implicated in the binding to M protein. Using a fusion protein containing two copies of the M5-HVR, we found that the Y402 and H402 variants of FH could be efficiently purified by single-step affinity chromatography from human serum containing the corresponding protein. Different M proteins vary in their binding properties, and the M6 and M5 proteins, but not the M18 protein, showed selective binding of the FH Y402 variant. Accordingly, chromatography on a fusion protein derived from the M6-HVR allowed enrichment of the Y402 protein from serum containing both variants. Thus, the exquisite binding specificity of a bacterial protein can be exploited to develop a simple and robust procedure to purify FH and to enrich for the FH variant that protects against AMD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Antigens, Bacterial / chemistry*
  • Antigens, Bacterial / metabolism
  • Bacterial Outer Membrane Proteins / chemistry*
  • Bacterial Outer Membrane Proteins / metabolism
  • Carrier Proteins / chemistry*
  • Carrier Proteins / metabolism
  • Chromatography, Affinity*
  • Complement Factor H / chemistry
  • Complement Factor H / genetics
  • Complement Factor H / isolation & purification
  • Complement Factor H / metabolism
  • Genetic Variation
  • Humans
  • Peptides / chemistry*
  • Peptides / metabolism
  • Protein Binding

Substances

  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • CFH protein, human
  • Carrier Proteins
  • Peptides
  • streptococcal M protein
  • Complement Factor H

Grants and funding

This work was supported by the Swedish Research Council (Project K2011-56X-09490-21-6), the Danish Strategic Research Council (Center for Nano-Vaccines), and the Foundation Olle Engkvist Byggmästare, the trust of Österlund (all to GL), the Swedish Government Support for Clinical Research (ALF) (to GL, MCUG and JL), and by the Royal Physiographic Society in Lund and the trust of Golje (to MCUG and JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.